Drugs

|

7

Innovent and Eli Lilly to Develop and Potentially Sell Novel Diabetes Medicine in China

Innovent Biologics, Inc. announced that it has entered into a licensing agreement with Eli Lilly and Company for the development and potential …

Astra Zeneca’s Drug Does Not Get FDA Approval for Type 1 Diabetes

AstraZeneca announced yesterday that the U.S. Food and Drug Administration (FDA) did not approve its diabetes treatment, Farxiga, for use as a …

|

Diabetes Drug Could be Used to Treat Common Heart Problem, Study Suggests

Researchers at the University of Arizona have discovered that metformin, a drug commonly used to treat type 2 diabetes, might also be used to treat …

| |

Diabetes Drug Has Positive Phase 3 Results in Large Study, Cutting Heart Risks

Astra Zeneca’s diabetes drug, Farxiga met primary endpoints in a large clinical study, showing a significant reduction in hospitalization rates …

|

FDA Issues Warning About Rare Infection with Commonly Used Diabetes Medication

The U.S. Food and Drug Administration is warning patients and doctors about a rare but serious infection that has been reported with a common class …

Diabetes Drugs Act as Powerful Curb for Immune Cells in Controlling Inflammation

When tissue is damaged, one of the body’s first inflammatory immune-system responders are macrophages, cells which are commonly thought of as …

|

New Diabetes Drug Shows Superior Improvement in HbA1c levels Compared to Jardiance

A new once-daily oral diabetes medication, semaglutide, was better at lowering blood sugar levels than Eli Lilly and Boehringer Ingelheim’s, …

| |